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Background: Reducing the duration of untreated psychosis (DUP) is an aspiration of international guidelines for
first episode psychosis; however, public health initiatives have met with mixed results. Systematic reviews suggest
that greater focus on the sources of delay within care pathways, (which will vary between healthcare settings) is
needed to achieve sustainable reductions in DUP (BJP 198: 256-263; 2011).
Methods/Design: A quasi-experimental trial, comparing a targeted intervention area with a ‘detection as usual’
area in the same city. A proof-of–principle trial, no a priori assumptions are made regarding effect size; key
outcome will be an estimate of the potential effect size for a definitive trial. DUP and number of new cases will be
collected over an 18-month period in target and control areas and compared; historical data on DUP collected in
both areas over the previous three years, will serve as a benchmark. The intervention will focus on reducing two
significant DUP component delays within the overall care pathway: delays within the mental health service and
help-seeking delay.
Discussion: This pragmatic trial will be the first to target known delays within the care pathway for those with a
first episode of psychosis. If successful, this will provide a generalizable methodology that can be implemented in a
variety of healthcare contexts with differing sources of delay.
Trial registration: http://www.controlled-trials.com/ISRCTN45058713
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Youth mental healthBackground
International studies have shown that the average length
of time from the onset of psychotic symptoms to first
treatment (duration of untreated psychosis; DUP) ranges
between 364 and 721 days [1] with recent meta-analyses
reporting an association between long DUP and poor
outcome at 6 and 12 months, for both symptoms and
quality of life. Drake et al. [2] suggest that the point at* Correspondence: c.s.connor@bham.ac.uk
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reproduction in any medium, provided the orwhich DUP exceeds three months, defines a critical point
after which the likelihood of poorer outcome begins to
increase, and several studies indicate that accessing
treatment within the first 6 months of onset is a key in-
dicator of outcome, specifically in terms of treatment re-
sponse [3-8].
Evidence for the efficacy of initiatives to reduce DUP,
however, is mixed [9]; the ‘TIPS’ study in Norway has
had the greatest success. Their prospective trial in a
defined health care region, incorporating the introduc-
tion of an early detection program alongside a public
health awareness campaign, achieved significant results
in comparison with parallel health care areas without anLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and associated with better clinical status and reduced
suicide risk at baseline and negative symptoms at 12
months, with positive effects on clinical and functional
status maintained at 5 year follow-up [10]. However,
similar public health initiatives in Australia [11] and
Canada [12] have failed to demonstrate any impact on
DUP.
Implementation of a TIPS style intervention in UK
healthcare settings, however, may prove ineffective as
the care pathway delays experienced by young people
with first-episode psychosis in UK may not be directly
comparable to those experienced in Norway. Rogaland
County is a dispersed population centred around the
predominantly Caucasian (95%) city of Stavanger [13];
approximately 60% of the population living in urban
areas [14]. In contrast, Birmingham, UK is the second
most populous city in Britain (1.05m) and the ‘youngest
city in Europe’ with 40% of its population under the age
of 20. It has a high degree of cultural and religious diver-
sity, including 68% White British residents, 20%
residents of Asian or Asian British heritage and 7% Black
or Black British, and includes the highest number of
residents from the Muslim faith in any UK local area for
whom help-seeking can include imams at the family
mosque; indeed, our recent study showed that religious
construction of psychosis is common [15].
In the UK, the widespread adoption of early interven-
tion in psychosis teams (EIS) have not led to a reduction
in DUP [16,17]; this is, perhaps, not surprising since
these teams are not resourced or equipped with any
community focused early detection function. Birming-
ham, UK, was the setting of the first early intervention
service in the UK, yet despite this it continues to experi-
ence long DUP [18]. Our cluster randomized trial to im-
prove early detection of psychosis focusing on primary
care [16] did not achieve reductions in DUP; further ana-
lysis revealed that the main sources of delay occurred else-
where in the care pathway, in particular, within mental
health services themselves and in help-seeking delay 16; 18.
A recent systematic review of interventions to reduce
DUP [1] concluded that greater focus on the sources of
delay within care pathways, (which will vary between
healthcare settings) is needed to achieve sustainable
reductions in DUP.
Recent data from the UK National EDEN study [19]
has confirmed that there are two primary sources of
delay: delay in help-seeking among both patients and
carers and delays within mental health services. The first
referral point to mental health services was found to
have the greatest impact on DUP: where the first point
of contact was for acute crisis (admission, home treat-
ment), delay within the mental health service was low;
where access was via a Community Mental Health Team(CMHT), delays were greatly extended. These findings
suggested that whilst improvements in help-seeking be-
havior are necessary, significant improvements within
mental health services themselves would be essential to
reduce DUP. In Birmingham, as part of the present
study, a youth access pathway into the mental health
service has been developed within the CMHT [20], pro-
viding a single referral point and ensuring that first epi-
sode cases of psychosis are managed in a youth sensitive
framework and guarantee direct access to the specialised
service.
Hypothesis
The primary hypothesis to be tested is whether imple-
mentation of a psychosis public health campaign in
addition to the youth access pathway for first episode
psychosis, will significantly reduce DUP.
Methods
Design
This is a quasi-experimental, proof-of-principle pro-
spective trial comparing an intervention area in the
south of the city, to the non-intervention remainder of
the city.
Incident cases of first episode psychosis from these
areas will be determined and their DUP and care
pathways ascertained over the following 18 months. We
also benefit from recent historical DUP data (National
EDEN) [19] for both target and control areas.
Sampling
Birmingham is served by a single mental health service,
which served as the ‘blueprint’ for the Government’s Na-
tional Service Framework for Mental Health [21]; it has
a number of community services including Home Treat-
ment and Assertive Outreach teams, including well-
developed early intervention services for first episode
psychosis which were the forerunner of such services
across England. It is the second most populous city in
Britain with a high degree of cultural and religious diver-
sity and is ranked third most deprived core city in England
[22]. Population and ethnic profile of the intervention and
control areas [23], together with the number of new cases
in the previous 12 months, is shown in Table 1.
Ethical approval
The trial is sponsored by Research and Innovation de-
partment at Birmingham & Solihull Mental Health
Foundation Trust. Advice was sought from the National
Research Ethics Service for the NHS. This public health
trial falls outside of the requirements for formal approval
as: no consent or recruitment of service users is required;
no identifiable data will be specifically collected or used
for evaluation; and the only data to be used will be
Table 1 Socio-demographic profile of intervention and
control areas
Population Ethnic profile
Intervention Area 308,150 85% White British
8% Asian
3% Black
Control Area 632, 427 62% White British
26% Asian
8% Black
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of which are routinely collected for all clients entering the
specialist Early Intervention Service (for first episode
psychosis) as part of their initial assessment.
The intervention
Context and theoretical framework
The ‘Precede-Proceed’ public health model framework [24]
has provided the foundation for this study using
assessments of context and setting to inform and guide the
development and implementation of the intervention. This
will ensure a responsive, stratified ‘knowledge-transfer’ ap-
proach is applied to reducing DUP. This framework is fur-
ther underpinned by two theoretical models of health
behaviour change addressing both cognitive and context-
ual determinants; the Trans-theoretical/Stages of Change
model [25] and the MINDSPACE framework [26], the lat-
ter arising from behavioural economics, widely employed
by UK policymakers [27].
Initial findings from the ‘Precede’ phase of our programme
have helped us clarify the likely reasons for delay in care
pathways and enabled comprehensive assessment, planning,
piloting and target-setting [18]. Patient and public involve-
ment was a fundamental aspect of this preceding phase, in-
volving discussion and consultation with an advisory board
comprising of young people and users of the mental health
services.
The ‘Proceed’ phase now focuses directly on imple-
mentation and evaluation of the intervention, but will,
nevertheless, continue to incorporate comprehensive
and iterative feedback at each stage to determine the
most successful methods of improving help-seeking and
youth care pathways.
Care pathway interventions
1. Improving help-seeking.
The aim of this component of the intervention is to
improve the help-seeking of young people and their
carers, who are experiencing symptoms of first-episode
psychosis through implementation of a psychosis aware-
ness campaign including information about when, where
and how to seek help. Individuals are encouraged to ac-
cess a helpline and a bespoke website.The campaign was launched in January 2012 and will
run for 18-months. Campaign staff, will be active at the
heart of the community, in local shopping centres and
supermarkets, at employment centres and community
events and will work closely with youth and community
groups. All campaign material bears the psychosis cam-
paign slogan, ‘Don’t turn your back on the symptoms of
psychosis’, the website link (www.youthspace.me/psych-
osis) and the information line number.
The campaign will be broken into 6 three-month
stages. Each stage comprising of the following elements:
i. Advertising in high use settings.
Campaign posters will be displayed in a variety of
settings, including local bus services and shopping
centres. Smaller leaflets and postcards will be
routinely distributed across the target areas
including supermarkets, employment offices,
community and youth groups, leisure centres, coffee
shops and fast-food outlets. Informed by our
pathfinder studies, the poster themes focus
specifically on young people, their friends and
parents/carers.
ii. Leaflet drops
Leaflets drops to homes on several large social
housing estates in hard-to-reach areas which have
no central shopping centre, high street or
supermarket.
iii. Advertising in community press
Posters and articles about psychosis, featuring
interviews with clinicians and service users, will
appear in community newspapers and magazines at
regular intervals throughout the campaign; these
monthly, bi-monthly and quarterly newspapers and
magazines are delivered free to homes in the target
areas.
iv. Advertising on community websites
Posters, on-going campaign information and articles
about psychosis will be routinely posted on 6
community websites and 10 library web-pages in the
target area.
v. Attendance at community events
Campaign volunteers and staff will attend a variety
of community and music events and also attend
student events at Universities and colleges in the
intervention area.
vi. Promotion of www.youthspace.me/psychosis
Launched in early 2011, our website offers advice,
resources, signposting, educational films, blogs and
social media access for young people, families/carers
and those who work alongside young people on all
aspects of mental health and well-being. For the
purposes of the psychosis campaign, a direct link to
the psychosis specific page of the website will be
Table 2 Number of incident cases and their DUP: August 2011 – August 2012
New
cases
DUP (mean;
median; sd)
Delay in help-seeking
(mean; median; sd)
Delay within mental health services
(mean; median; sd)
Delay in accessing EIS
(mean; median; sd)
Intervention
Area
88 293; 38 (867.1) 50; 0 (131.6) 211; 30 (481.4) 443; 56 (930)
Control Area 250 264; 58 (539) 114; 3 (271.4)113 213; 22 (511.9) 323; 105 (560.8)
Table 3 Confidence Intervals for the target area based on
predicted increase in referral rate
Yearly referral rate
increase
Predicted confidence
Interval (+/−)
CI width
30 218 90-526
40 187 121-495
50 166 142-474
60 151 157-459
70 139 169-447
80 130 178-438
90 123 185-431
100 116 192-424
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psychosis, the benefits and importance of early help-
seeking, and where to go to seek help.
vii. The Psychosis Information line
A psychosis information line features on all
campaign material, offering an alternative way of
help seeking for those who would rather speak to
trained advisors about their concerns or for those
who have no access to a computer. A similar line
was utilised in the TIPS study. Its main function will
be to provide callers with information about
psychosis, send out information packs and facilitate
access to a clinician for further assessment where
appropriate.
viii.Youth Advisors
Youth advisors will regularly update the campaign
with photographs, video footage and blogs by those
who have experienced mental health issues and
ensure we utilise timely and age appropriate creative
strategies to engage with young people.
ix. Psychosis Awareness Training
We will collaborate with Emergency Services, youth,
community, employment and education agencies to
provide psychosis awareness training; this will enable
greater outreach into the community and create a
broad network of organisations and individuals
through which the campaign can be targeted.
2. Youth mental health care pathway.
A youth access care pathway was developed operating
alongside existing CMHTs in the intervention area and
provides direct referral channels and immediate assessments
for all young people presenting to primary care with mental
health difficulties aged 14–25 [20]. The service was
established to improve the care pathways of young people
ensuring that all cases of first episode psychosis have direct
access to EIS, enabling and maintaining good levels of
engagement with young people from their earliest
presentation.
Inclusion and exclusion criteria
All new cases of first episode psychosis accepted by the
Early Intervention in psychosis Service.
Patients considered at ultra-high risk of psychosis,
using the Comprehensive Assessment of At Risk
Mental State (CAARMS) [28] are excluded. Since this
is a pragmatic trial focussing on reducing DUP inpatients managed within an EIS, there will be no
other exclusions.
Measures
DUP is routinely calculated for all clients with a first epi-
sode of psychosis at entry into EIS services, employing a
combination of retrospective assessment of positive and
negative symptoms of psychosis (SCI-PANSS) [29],
Pathways to Care interview [30] and electronic care
records. This is based on the method described by
Larsen et al [10] and used in our research [18].
The Pathways to Care interview follows the method of
Gater et al. [30] in which systematic information is
gathered from direct interview and electronic care
records about the source, sequence and timing of help-
seeking by patients and their families, including help-
seeking contacts, the main problems presented and
treatments offered. This included the sequence and dur-
ation of contacts within the mental health service. We
also documented any mental health service contact prior
to the formal onset of psychosis. These data were
synthesised onto visual ‘route timelines’; presenting the
sequence of help-seeking contacts, referrals made, diag-
noses offered, treatment provided and outcomes.
All DUP interviews are conducted by graduate re-
search psychologists, who have satisfactorily completed
five DUP calculations, reproducing scores pre-defined by
trainers [18]. Each interview takes approximately 1 hour
to complete and research staff undergo 6-monthly
checks on their assessment reliability, consisting of sub-
mission of five timelines and DUP calculations to DUP
co-ordinators for concordance and standardisation of
calculation. Continual feedback and assistance from co-
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ensure inter-rater reliability.
Primary outcome
DUP
We hypothesise that our psychosis awareness campaign,
in combination with the introduction of the youth fo-
cused clinical access team, will significantly reduce DUP.
Secondary outcome
Referral rates
We also predict an increase in referrals of young people
diagnosed with a psychotic disorder from the interven-
tion area into EIS.
Table 2 shows baseline DUP and component delays for
incident cases in between August 2011 and August 2012.
Primary analysis
DUP and referral rates for intervention area compared
to the control area will be monitored and evaluated
every three months throughout implementation and at
the culmination of the intervention (2 year period). In
the TIPS study, despite DUP being relatively short in
both areas (with a combined median of 10 weeks), DUP
was significantly reduced in the intervention area,
reduced to a median of 5 weeks compared with 16
weeks in the control area [31]. In this proof-of-principle
trial, we make no a priori assumptions about effect size
since the methodology and setting is unique. The key
outcome of this trial will be an estimate of the effect
size, which will inform a definitive trial. The confidence
intervals for different levels of increase in the number of
new referrals in the target area are shown in Table 3.
Secondary analysis
Website visits
We also predict there will be an increased number of
online visits to our website www.youthspace.me/psych-
osis. The website went live in September 2011. Website
visits will be monitored on a monthly basis before, dur-
ing and after the intervention.
UK benchmark DUP data
The trial benefits from extensive DUP data from UK Na-
tional EDEN sites in Cambridge, Cornwall, Blackburn,
Blackpool, Burnley, Lancaster and Norwich [18].
Discussion
Although reducing DUP is a UK Department of Health
target, there has been no effective strategy for achieving
this in the UK. This is the first UK trial attempting to re-
duce DUP. The ethnic profile of Birmingham, however,
is diverse and includes large numbers of inhabitants of
Asian and Black heritage, therefore, any findings fromthis intervention, will be need to be carefully considered
in light of this diversity. Our application of the Precede/
Proceed public health model in the design and imple-
mentation of the trial, nonetheless, will provide a
generalizable methodology that should be applicable to a
variety of healthcare contexts with differing sources of
delay.
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